Weinzweig N, Schuler J
Division of Plastic Surgery, University of Illinois at Chicago 60612-7316, USA.
Ann Plast Surg. 1997 Jun;38(6):611-9. doi: 10.1097/00000637-199706000-00008.
We propose that a long-term cure for the recalcitrant chronic venous ulcer must involve a dual surgical approach including (1) wide excision of the ulcer and surrounding liposclerotic tissue bed, and (2) replacement by a free flap containing multiple, competent microvenous valves with a normal microcirculation. Advantages of free flaps over skin grafting include improvement of the underlying pathophysiology; increase in blood supply to the area; ability to cover exposed bone, joint, or tendon; and a lower incidence of recurrence. During the past 8 years, 20 consecutive muscle free flaps were performed in 18 patients for 19 recalcitrant venous ulcers (two "sequential" flaps to the ipsilateral leg in 1 patient and a repeat flap after initial failure in 1 patient). Twelve males and 6 females ranged in age from 17 to 76 years (mean, 44 years). Nontraumatic, nonosteomyelitic venous ulcers had been present for an average of 3.5 years (range, 1-10 years) and failed an average of 2.4 skin grafts (range, 0-6 grafts). Defects ranged from 100 to 600 cm2 (mean, 238 cm2). Donor tissues included rectus abdominis (N = 13), latissimus dorsi (N = 5), gracilis (N = 1), and serratus (N = 1) muscles. Recipient vessels included posterior tibial (N = 12), anterior tibial (N = 6), and peroneal (N = 2). In all instances except one, only one vein, usually one of the venae comitantes, was anastomosed in end-to-end fashion. Successful free tissue transfer was accomplished in 18 of 20 flaps (90%). Complications included infection with partial flap and/or skin graft loss (three flaps), and partial skin graft loss (two flaps). There were no recurrences within the flaps; however, breakdown occurred at the junction between the flap and residual adjacent liposclerotic skin in 1 patient. Follow-up average 32.7 months (range, 8-65 months); 3 patients were lost to follow-up. Free muscle transfer can provide a long-term cure for the recalcitrant venous ulcer by replacing the diseased tissue bed with healthy tissue containing multiple, competent microvenous valves and a normal microcirculation. This can be accomplished in one reconstructive procedure with excellent long-term results.
我们认为,顽固性慢性静脉溃疡的长期治愈必须采用双重手术方法,包括:(1)广泛切除溃疡及周围的脂肪硬化组织床;(2)用含有多个功能正常的微静脉瓣膜且微循环正常的游离皮瓣进行替代。游离皮瓣相对于皮肤移植的优点包括改善潜在的病理生理状况;增加该区域的血液供应;能够覆盖外露的骨骼、关节或肌腱;以及复发率较低。在过去8年中,18例患者因19处顽固性静脉溃疡接受了连续20次游离肌皮瓣移植手术(1例患者同侧腿部进行了2次“序贯”皮瓣移植,1例患者初次失败后进行了再次皮瓣移植)。患者中男性12例,女性6例,年龄在17至76岁之间(平均44岁)。非创伤性、非骨髓炎型静脉溃疡平均存在3.5年(范围1至10年),平均进行过2.4次皮肤移植失败(范围0至6次移植)。溃疡面积从100至600平方厘米不等(平均238平方厘米)。供体组织包括腹直肌(13例)、背阔肌(5例)、股薄肌(1例)和前锯肌(1例)。受体血管包括胫后血管(12例)、胫前血管(6例)和腓血管(2例)。除1例情况外,所有病例均仅吻合1条静脉,通常为1条伴行静脉,采用端端吻合方式。20例皮瓣中有18例(90%)成功完成了游离组织移植。并发症包括感染伴部分皮瓣和/或皮肤移植失败(3例皮瓣),以及部分皮肤移植失败(2例皮瓣)。皮瓣内未出现复发情况;然而,1例患者皮瓣与残留的相邻脂肪硬化皮肤交界处出现破溃。随访平均32.7个月(范围8至65个月);3例患者失访。游离肌皮瓣移植可通过用含有多个功能正常的微静脉瓣膜且微循环正常的健康组织替代病变组织床,为顽固性静脉溃疡提供长期治愈方案。这可在一次重建手术中完成,并取得优异的长期效果。